Khalid Usman, Mujeeb ur Rehman, Arif Mumtaz, Naseeb UrRehman, and Salman Khan. “EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 28, no. 2, July 2021, pp. 418-22, doi:10.53555/jptcp.v28i2.6807.